Page 25 - COVID-19-Mortality-review-in-Malaysia-and-updates-on-clinical-management-of-COVID-19
P. 25

Anti - inflammatory / immunomodulatory agents


               This is an early study conducted in Germany that looked at Interleukin 6 (IL-6) levels
               in 40 patients. One-third of them required ventilation [1].   If you look at IL-6 level,

               when IL-6 < 80 pg/ml, only 4% required intubation. When the IL-6>80 pg/ml, about
               92% of them required intubation. The Il-6 started going up about 1.5 days before

               intubation. It sort of tells us that the IL-6 level predicted people who need intubation.
               So, there is an inflammatory response that needs to be tackled when we control
               COVID-19.



































                   Diagram 9: COVID-19 patient with elevated IL-6 are at risk for respiratory failure
               may   require   ventilatory   support   (Image   courtesy   of   Emory   Internal   Medicine

               Residency: COVID-19 visual series)
   20   21   22   23   24   25   26   27   28   29   30